Source: Virtual Congress 2021 – Environment and respiratory health



Rating:

Share or cite this content

Citations should be made in the following way:
E. Fireman Klein (HAIFA, Israel), Y. Elimelech (HAIFA, Israel), L. Majdoub (HAIFA, Israel), Y. Adir (HAIFA, Israel), M. Shteinberg (HAIFA, Israel). Ultrafine particles in airways during COVID-19 lockdown. 104

Member's Comments

No comment yet.

Related content which might interest you: Retention of ultrafine particles in the human lung Source: Eur Respir J 2004; 24: Suppl. 48, 236s Year: 2004 Trajectory of inhaled cadmium ultrafine particles in smokers. Source: Virtual Congress 2021 – Chronic airway, interstitial, pleural and neoplastic diseases Year: 2021 Extrapulmonary effects of inhaled ultrafine carbon particles in mice Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Deposition of ultrafine (nano)particles in the human lung and the mechanisms behing the health effects Source: International Congress 2014 – Nanomaterials and respiratory health Year: 2014 Negligible clearance of ultrafine particles retained in healthy and affected human lungs Source: Eur Respir J 2006; 28: 286-290 Year: 2006 Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD Source: Eur Respir J 2003; 21: 47S-51S Year: 2003 Respiratory effects of vehicle exhaust ultrafine particles versus secondary ultrafine particles in ambient air Source: International Congress 2016 – Population-based insights into occupational and environmental lung disease Year: 2016 Ultrafine carbon particles impair the phagocytic function of human alveolar macrophages Source: Eur Respir J 2002; 20: Suppl. 38, 21s Year: 2002 The generation of monodisperse pharmacological aerosols using a spinning-top aerosol generator (STAG) Source: Eur Respir J 2005; 26: Suppl. 49, 125s Year: 2005 Inhalation of nano-scaled titianium dioxide particles aggravates airway inflammation in allergen-challenged mice Source: Annual Congress 2011 - Environmental exposure and disease mechanisms Year: 2011 Development of an in vitro pulmonary translocation system for ultrafine particles Source: Eur Respir J 2005; 26: Suppl. 49, 387s Year: 2005 Welding fumes change the lipid composition of particles in exhaled air. Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation Year: 2018 Bioreactivity and fate of nanoparticles deposited at the pulmonary epithelial interface: focus on traffic-derived particulate matter Source: International Congress 2016 – Traffic air pollution in urban areas Year: 2016 Measuring peripheral lung dimensions with the deposition of aerosol nanoparticles Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 No evidence electric charge increases inhaled ultrafine particle deposition in human lungs Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease Year: 2020 Fate of inhaled ultrafine carbon particles after one week; human exposure using a novel aerosol with 111indium Source: Annual Congress 2012 - Air pollution: from the particles in town to the pollutants in the countryside Year: 2012 Airway inflammation in iron ore miners exposed to dust and diesel exhaust Source: Eur Respir J 2006; 27: 714-719 Year: 2006 Exposure to ultrafine particles and respiratory hospitalisations in five European cities Source: Eur Respir J 2016; 48: 674-682 Year: 2016